Researching a New Potential Option for Psoriasis

The EVERLAST-A Study for Psoriasis - Now Enrolling

Millions of adults struggle with psoriasis and the constant battle against flare-ups. Although there are many treatments available, they do not always address the underlying source of inflammation. This is why doctors and researchers are working to develop new medications that may better treat psoriasis in the future.  

If you’re living with psoriasis but have not found sustained relief from other treatments, you may qualify for the EVERLAST-A Study. The study is evaluating an investigational medication that is injected under the skin to see if it can help relieve the pain, itch, skin irritation, and other symptoms caused by psoriasis.

If you qualify and choose to join the EVERLAST-A Study, you will receive study-related care at no cost, and will be compensated for your time and travel to attend any required study visits.

Get Notified About Upcoming Trials

Sign up to receive information about clinical trials, studies, and surveys in your area – right to your inbox.

Sign up

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2025 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.